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The COVID-19 pandemic of 2020 is a major global 
health challenge. At the time of writing, over 11.6 million 
people around the world had been registered as infected 
and 538,000 had died (Worldometers, 2020, accessed 
July 7, 2020). Public health responses to COVID-19 
need to balance direct efforts to control the disease and 
its impact on health systems, infected people, and their 
families with the impacts from associated mitigating in-
terventions. Such impacts include social isolation, school 
closure, health service disruption stemming from recon-
figuring health systems, and diminished economic activ-
ity. The primary focus of both the United Nations (UN) 
and the World Health Organization (WHO) has been on 
addressing COVID-19 as a physical health crisis, but the 
need to strengthen mental health action, including sui-
cide prevention, is increasingly recognized, as is the need 
for mental health research to be an integral part of the 
recovery plan (UN, 2020a). The impacts of the pandem-
ic on physical and mental health will unfold differently 
over time and will vary depending on the duration and 
fluctuating intensity of the disease. Research is needed 
to help ensure that decision-making regarding all aspects 
of health, including mental health (Holmes et al., 2020), 
is informed by the best quality data at each stage of the 
pandemic.
The pandemic poses a prolonged and unique challenge 
to public mental health, with major implications for sui-
cide and suicide prevention (Gunnell et al., 2020; Reger, 
Stanley, & Joiner, 2020). A rise in suicide deaths in the 
wake of the pandemic is not inevitable. There is consensus, 
however, that the mitigation of risk will be contingent upon 
a proactive and effective response involving collaborative 
work between the state, NGOs, academia, and local gov-
ernments and coordinated leadership across government 
ministries, including health, education, security, social 
services, welfare, and finance. Countries have responded 
in different ways to the pandemic, effectively creating a 
series of natural experiments. Thus, regions of the world 
affected later in the pandemic can draw on lessons from 
countries, such as China and Italy, affected in its early 
phase. Likewise, lessons learned early in the pandemic 
(e.g., on the impact of lockdown and physical distancing 
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measures) can be used to inform responses to any future 
surges in the incidence of COVID-19.
Although there are important parallels between coun-
tries in the course of the pandemic, some stressors, re-
sponses, and priorities are likely to differ between high- 
and low–middle-income countries and between cultures 
and regions. As COVID-19 appears to be disproportion-
ately affecting Black, Asian, and minority ethnic communi-
ties, the response – and suicide prevention research carried 
out to inform the response – needs to be sufficiently granu-
lar and account for the complexity of risks in these groups 
(O’Connor et al., 2020).
Throughout this editorial, when we refer to suicide and 
suicidal behavior, we mean to include both fatal and nonfa-
tal suicidal behaviors and self-harm.
The Need for Evidence-Based 
 Suicide Prevention Responses 
Suicide is the most extreme outcome of a mental health 
crisis and should therefore be a key priority in any broad-
er mental health response to the pandemic (Gunnell et al., 
2020; Reger et  al., 2020). Suicide prevention responses 
need to be informed by research that is as specific as possi-
ble to the current situation and takes account of the many 
mechanisms that have an impact on suicide, as they may 
vary during the different phases of the pandemic. At the 
same time, given the risks involved, strategic development 
of policy and implementation responses cannot wait until 
all aspects of the epidemiology and consequences of the 
disease on mental health and risk of suicide are under-
stood. 
The dilemma here is that few studies have investigated 
the impact of previous pandemics – or even epidemics – on 
suicide (Cheung, Chau, & Yip, 2008; Wasserman, 1992; 
Zortea et al., 2020), and none has evaluated suicide pre-
vention measures in the current context. An analysis of the 
impact of the Spanish Flu epidemic (1918–1920) in the 
United States indicated that it resulted in a small rise in su-
icides (Wasserman, 1992). Cheung and colleagues (2008) 
reported a rise in suicide among older people during the 
2003 SARS epidemic in Hong Kong. Similarly, what can be 
learned from other types of public health emergencies is 
limited. Much of the related research comes from one-off 
events, such as terrorist attacks and natural disasters (e.g., 
earthquakes). Findings from such events might not be ap-
plicable to the current situation (Devitt, 2020).
Early Research Findings Relevant 
to Assessing the Impact of  
COVID-19 on Mental Health 
Early publications relevant to the COVID-19 response 
have largely come from literature reviews, small selective 
surveys or case reports, often using indirect measures of 
suicide risk or from modeling approaches to predict the 
impact of the pandemic. These have addressed issues such 
as the impact of quarantine (Brooks et al, 2020), highlight-
ed possible high-risk groups (Yao, Chen, & Xu, 2020), and 
assessed mental health service disruption (Royal College 
of Psychiatrists, 2020). 
Physical distancing and related measures, which have 
been at the forefront of the public health response, carry a 
strong risk of increasing isolation, particularly in vulnera-
ble populations such as older people and people who have 
been bereaved (Brooks et al., 2020; De Leo & Trabucchi, 
2020; Wand, Zhong, Chiu, Draper, & De Leo, 2020; Yip & 
Chau, 2020). Physical distancing measures may also lead 
to increases in household stress levels, domestic violence, 
and alcohol misuse and affect the accessibility of mental 
health services (Brooks et  al., 2020; Reger et  al., 2020). 
The stresses of lockdown may be worse in low- and mid-
dle-income countries where extended families tend to live 
together with limited housing space. 
Concerns have been expressed about increases in de-
mand for psychiatric emergency care (Royal College 
of Psychiatrists, 2020). In the context of overwhelmed 
health-care systems and shortages of resources to treat 
people with COVID-19 in healthcare settings, qualitative 
findings from China indicate that the intensity of work dur-
ing the pandemic drained health-care workers physically 
and emotionally (Liu et al., 2020). In the United Kingdom, 
the British Medical Association well-being support servic-
es have seen a 40% increase in use after the onset of the 
pandemic (Torjesen, 2020). 
Positive effects of the pandemic on the public, such as 
increased prosocial behavior (e.g., donating and volun-
teering) and the strengthening of community ties, may 
help to mitigate detrimental impacts of physical distanc-
ing (Van Bavel et al., 2020). The move of some health and 
third-sector services into online settings may also have 
long-lasting benefits in improving service accessibility, 
particularly to those who find face-to-face consultation dif-
ficult. The effect on people with mental illness of replacing 
face-to-face treatment with remote delivery of care, how-
ever, remains unclear. Moreover, in low- and middle-in-
come countries the technology to support remote assess-
ment is limited (De Sousa, Mohandas, & Javed, 2020; UN, 
2020a). In these, and other settings, where there is limited 
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access to specialist mental health services, community and 
peer support becomes extremely important. 
The potential for the COVID-19 virus to affect the brain 
and to cause long-lasting physical morbidity means it 
might become relevant as a risk factor for mental illness 
and suicide in the future (Holmes et al., 2020; Rogers et al., 
2020; Wu et al. 2020). Review findings indicate that the 
incidence of psychosis, a major risk factor for suicide and 
suicidal behavior, appeared to be high in people following 
SARS, MERS, and H1N1 infection (Rogers et  al., 2020). 
Given emerging evidence that the virus can have severe ef-
fects on different organ systems including kidney and liver 
function (Zhang, Shi, & Wang, 2020), the physical conse-
quences of infections might include a prolonged reduction 
in functional capacity and disability in some patients, all 
of which might have potential implications for suicide risk 
and prevention. 
However, longer-term risks for suicide are likely most 
closely related to the economic consequences of the pan-
demic, including financial strain and unemployment. In a 
study based on suicide data from 54 countries, the reces-
sion of 2008 was associated with a 3.3% increase in su-
icides in men (but not women) in the following year and 
more prolonged increases in several countries (Chang, 
Stuckler, Yip, & Gunnell, 2013). The increase varied de-
pending on the regional depth of the recession and the 
specifics of the social insurance systems (e.g., regulations 
for unemployment benefits or payed sick leave; Chang 
et al., 2013; Norström & Grönqvist, 2015). The economic 
downturn associated with the COVID-19 pandemic may 
be more rapid in onset than the 2008 recession and may 
push an estimated 500 million people, particularly in low- 
and middle-income countries, below the poverty line (UN, 
2020b).  
Early Research Findings Relevant 
to Assessing the Impact of COVID-19 
on Suicide and Suicidal Behavior 
There is, as yet, no direct evidence of the impact of the 
pandemic on suicidal behavior. While a number of news 
stories from Japan, New Zealand, and Germany report a 
decrease in suicides in the period around the time of lock-
down (Deutsche Welle, 2020; New Zealand Herald, 2020; 
The Guardian, 2020), these are all based on preliminary 
data/anecdotal reports and unsubstantiated by peer-re-
viewed publications. General population survey findings 
from the United Kingdom have shown no clear evidence 
of a rise in reported self-harm during the weeks following 
lockdown (after March 23), but no pre-lockdown data are 
available (Fancourt, Bu, Mak, & Steptoe, 2020). Many sur-
veys have been carried out in the wake of the pandemic, 
these often use convenience samples, which are prone 
to selection bias (Pierce et  al., 2020). In addition, there 
have been multiple case reports from some low- and mid-
dle-income countries highlighting occurrences of suicide 
thought to be related to COVID-19 (De Sousa et al., 2020; 
Mamun & Ullah, 2020). These reports must, however, be 
interpreted with great caution – and even more so when 
they are based on mass media reports, which are unlikely 
to have been validated.   
Some researchers have attempted to model the possible 
pandemic-associated increase in suicides, largely based on 
predicted rises in unemployment (Kawohl & Nordt, 2020; 
McIntyre & Lee, 2020; Moser, Glaus, Frangou, & Schech-
ter, 2020). Risk estimates vary widely, from a 1% increase 
in global suicides (Kawohl & Nordt, 2020) to a doubling of 
national suicides in a Swiss study, using prison incarceration 
as a questionable proxy for modeling the social distancing 
effects of lockdown (Moser et al., 2020). These discrepan-
cies are partly due to differences in modeling assumptions, 
which are associated with considerable uncertainty and 
may be very misleading. Given the uncertainty of the base-
line assumptions about how events will unfold, the results 
of these tentative projections can at best provide a guide as 
to where action should be directed but are largely unhelpful 
for accurate quantifications of future suicidal behavior and 
suicide.
 In this regard, access to real-time suicide mortality 
data is a key priority (Gunnell et al., 2020). Further, active 
surveillance systems for suicide attempts are warranted 
(WHO, 2016).
In the absence of direct evidence about trends in su-
icide, some researchers have used search behavior on 
Google Trends for terms related to suicide, as a proxy for 
suicide risk (Knipe, Evans, Marchant, Gunnell, & John, 
2020; Sinyor, Spittal, & Niederkrotenthaler, 2020). Their 
findings indicate that, although relative search volumes for 
financial and work-related concerns have increased (Knipe 
et al., 2020), searches for suicide and suicide methods have 
not (Knipe et al, 2020; Sinyor et al., 2020). The potential 
limitations of Google search data for surveillance are well 
recognized and include uncertainty about the algorithms 
used and issues with the stability of findings provided by 
Google Trends, as well of inconsistent associations with 
suicide (Tran et al., 2017).
Gaps in knowledge about the epidemiology of suicide 
and suicidal behavior during COVID-19 and the effective-
ness of intervention and prevention measures underline 
the need for a strategic approach to suicide research and 
prevention at a global level. The uncertainties regarding 
the direct and indirect effects of COVID-19 on suicide 
can only be addressed with good-quality tailored research. 
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Furthermore, suicide prevention in the age of COVID-19 
needs to build on what we know about the effectiveness 
of various measures, but also needs to take account of the 
unique challenges posed by the situation in order to devel-
op novel approaches. Our knowledge is currently still very 
limited and building the evidence base on suicide preven-
tion is crucial. 
Research Considerations  
During COVID-19 
There are several considerations in relation to suicide pre-
vention research carried out during crisis situations and 
in the present global pandemic (Table 1). These include 
ensuring the safety of research participants and research-
ers as well as the need for research to focus on low- and 
middle-income settings as well as high-income countries, 
keeping in mind that findings from one setting may not 
generalize to another. We expand on a few specific issues in 
the following section. First, the limited research conduct-
ed thus far on suicide and its prevention during COVID-19 
has focused mostly on high-income countries. While com-
plementary research in this area in low- and middle-in-
come countries should be prioritized, the poor quality of 
routine mortality and hospital attendance data as well as 
the limited availability of resources to carry out research 
in many of these settings present very real challenges. In 
2014 the WHO considered that only just over one third of 
member states had good-quality suicide registration data, 
and such data were largely absent in low- and middle-in-
come countries (WHO, 2014). The establishment of senti-
nel sites to gather as accurate data on suicidal behavior as 
possible to supplement those that already exist would be 
one way forward (WHO, 2016). 
Second, as a result of the pandemic, mental health ser-
vices have had to develop new ways of working to deliver 
care to suicidal individuals, including new care pathways, 
the mass roll-out of remote consultation, and increased 
use of digital interventions. These new ways of working 
require real-time evaluation and ongoing adaptation in 
response to findings. Traditional evaluation approaches, 
such as randomized trials, may need to be adapted in a 
manner that is still consistent with making robust infer-
ences about their effectiveness.
Third, with school and university closures in place in 
a number of countries, the traditional setting for carry-
ing out research into children and young people’s health 
is no longer available. Given current concerns about the 
impact of the pandemic on young people, mental health 
researchers will need to find alternative routes to study-
ing the impact of the pandemic on this potentially vulner-
able group. 
Fourth, for all studies it is vital that those with lived ex-
perience of suicide are involved in shaping the research at 
all stages – from developing the research questions to data 
Table 1. Considerations for suicide and suicidal behavior research during the COVID-19 pandemic
Research considerations
The COVID-19 suicide research response should be truly multidisciplinary. This will foster research that addresses the different aspects and 
layers of risk and resilience relating to the health consequences of COVID-19, including suicide and suicidal behavior. It will also foster research 
that informs prevention efforts by taking a range of perspectives.
People with lived experience of suicide should be involved at all stages of the research process.
Researchers should ensure that key risk groups that are often under-represented in suicide research are represented appropriately in studies.
The safety and well-being of participants should remain at the forefront of research design considerations.
Researchers’ safety must not be compromised if they are carrying out field work in situations where they may be at increased risk of infection.
Researchers should embrace Open Science research practices, such as registering research questions in advance and sharing data, wherever 
possible.
To ensure research findings inform practice, researchers should consider the potential real-world impact of their studies during the design 
phase and develop a clear, a priori dissemination strategy.
Research findings, particularly those making bold statements about risk or about effective treatments, should be peer reviewed prior to 
dissemination. If researchers decide that early dissemination is warranted, outputs should clearly state the preliminary status of the research 
and that it is yet to be peer reviewed. In this case, conclusions should be stated cautiously, in a manner that is consistent with the preliminary 
nature of findings.
When talking about research findings with the media, researchers should remain vigilant about not increasing risk for people who are already 
vulnerable. They should take care not to contribute to sensationalist headlines, should not make monocausal attributions of suicide to 
COVID-19, and should not use stigmatizing language (e.g., COVID-19 suicides). Researchers should recommend that media professionals use 
COVID-19-specific media reporting guidelines (see IASP, 2020b).
Research teams should be supported, particularly because some team members will be working in difficult home circumstances and many will 
be personally affected by concerns about the pandemic and its consequences.
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collection and dissemination of the findings. Fifth, all re-
search needs to comply with ethical standards. Research-
ers who do not normally work in the area of mental health 
and suicide prevention but who are now shaping conversa-
tions on suicide prevention need to obtain necessary train-
ing and background information on how to conduct suicide 
research, including the need to follow established research 
protocols and safety considerations that are specific to the 
field (Townsend, Nielsen, Allister, & Cassidy, 2020). Sixth, 
it is important that research resources (i.e., staff, funding) 
are rapidly mobilized to ensure timely research evidence 
is available. However, this presents tensions between the 
time researchers have available to write robust funding 
applications, time-scales for the grant review by fund-
ing bodies, and, if funded, the availability of high-quality 
fieldworkers and analysts as these are likely to be already 
committed to other projects. Flexibility and clear commu-
nication with funders about project delays and re-alloca-
tion of resources should help ameliorate these challenges. 
There is a distinct possibility that research funding may be 
adversely affected by a post-pandemic recession. Seventh, 
any proposed research should have a clear pathway to im-
pact to ensure that clinicians and policy-makers can imple-
ment the findings of research in their work.
Lastly, traditional models of research publication, with 
the need for peer review, introduce delays between article 
submission and on-line publication, reducing the speed 
with which evidence is disseminated and recommenda-
tions implemented. One solution is the fast-track review 
processes for selected papers – these were already in place 
before COVID-19, but have been extended and adopted 
by more journals since the beginning of the outbreak. An-
other solution is open science publication models that in-
volve on-line publication of articles while they await peer 
review, although there is a danger of low-quality research 
findings being disseminated and acted upon precipitous-
ly, without scrutiny of their validity (Armstrong, 2020). In 
order to mitigate this risk, researchers need to label their 
findings as preliminary and implement a communications 
strategy that addresses the preliminary nature of findings. 
The International COVID-19 Suicide 
Prevention Research Collaboration 
High-quality timely research to understand the suicide-re-
lated consequences of COVID-19 and to determine how 
best to mitigate the risk stemming from these consequenc-
es is now needed. The UN highlights the need for “rapid 
knowledge acquisition,” establishing research priorities, 
coordinating research efforts, open-data sharing, and 
funding (UN, 2020a). In response to widespread concerns 
about the impact of the COVID-19 pandemic on suicide 
and suicidal behavior, a group, initially consisting of 44 su-
icide prevention researchers and leaders of suicide preven-
tion charities from around 20 countries, came together to 
pool their expertise about the likely impact of the pandemic 
on suicidal behavior and to identify prevention priorities. 
The International COVID-19 Suicide Prevention Research 
Collaboration (ICSPRC) sought to include at least one repre-
sentative from many of the most affected countries and also 
representation from high-, middle-, and low-income coun-
tries (https://www.iasp.info/COVID-19_suicide_research.
php). The ICSPRC assessment of the risks posed by the 
pandemic and suggested responses to mitigate these were 
summarized in a Lancet Psychiatry commentary published 
in April 2020 (Gunnell et al., 2020). 
Building on this initiative, the collaborative network has 
been extended to include suicide researchers from a wider 
range of countries (including countries in Africa, the Mid-
dle East, and South America), with skills ranging from pop-
ulation health to biological psychiatry and incorporating 
expertise in quantitative and qualitative methods, together 
with ethics. The objectives of the group are to:
a) Share early findings (and, where appropriate, data) on 
the impact of the pandemic, and the public health meas-
ures (e.g., physical distancing) to contain its spread, on 
suicidal behavior in participants’ countries and to pro-
vide timely policy advice to those in other countries.
b) Facilitate collaboration/avoid duplication through shar-
ing information about ongoing research studies and 
COVID-19 research tools/questionnaires focused on 
suicide prevention, as well as advice about study design. 
c) Harmonize data collection approaches to facilitate 
pooling of data, where possible, from different settings 
and contexts.
An early example of the success of this approach has been 
the collaboration between two groups working on almost 
identical systematic reviews investigating the impact of 
pandemics/epidemics on suicide, self-harm, and suicidal 
ideation (Zortea et  al., 2020). Another group has estab-
lished real-time surveillance of the emerging literature on 
 COVID-19 and suicide to become a “living review” (John 
et  al., 2020). The global distribution of group members 
will facilitate rapid combined efforts in response to fund-
ing opportunities, where cross-national studies would 
strengthen the evidence base. 
Conducting high quality suicide prevention research 
is challenging. Suicide, in population terms, is a low-inci-
dence event and thus studies are often under-powered to 
identify small but potentially important effects. Further-
more, a focus on intermediate or proxy outcomes (e.g., 
self-reported suicidal ideation) is sometimes necessary but 
these have a questionable relationship to suicidal behav-
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Table 2. Example research questions relating to whether rates of suicide and/or suicidal behavior increase as a result of the pandemic and what 
mechanisms may be driving any increase
General population
Variations across time, place, and person
Time What is the impact of the pandemic on suicide and suicidal behavior and does risk differ over its course and in its aftermath?
Place Are there underlying country- or region-level differences that may explain differing changes in rates of suicide and suicidal be-
havior? For example, do the background rates of suicide and suicidal behavior seem to have a bearing on any increases? What 
about the number of COVID-19 cases and deaths, the capacity of the health-care system, and the pandemic response? Are any 
observed relationships the same for low- and middle-income countries as they are for high-income countries?
Person Does any change in the incidence of suicide and suicidal behavior vary by population subgroup? For example, is there vari-
ation by demographic factors (e.g., age, gender, ethnicity, religious affiliation), household structure (e.g., living alone, living 
with children, living with joint/extended families), socioeconomic factors (e.g., socioeconomic status, job loss, financial 
strain, debt, access to resources, occupation)?
Risk, protective, and new individual-level factors
Risk factors Are there recognized risk factors for suicide and suicidal behavior that are heightened during the pandemic that might 
 explain any increases? For example, how do any changes in suicide and suicidal behavior relate to changes in levels of 
anxiety, depression, alcohol use, or feelings of entrapment that might be increased by isolation, loneliness, uncertainty, 
domestic violence, economic hardship, and reduced social participation?
Protective 
factors
Are there recognized protective factors for suicide and suicidal behavior that might be bolstered during the pandemic and 
potentially keep rates of suicide and suicidal behavior from increasing? For example, if communities rally around and pro-
vide support for those who might be vulnerable, does this have a positive impact?
New factors Are there new risk or protective factors for suicide and suicidal behavior that correspond to the emergence of the pandem-
ic? Are there risk or protective factors that have been exacerbated or changed in importance? For example, has face-to-face 
and online racism against Asian people during the pandemic led to an increase in their risk of suicidal behavior?
Population-level factors
Access to the 
means
Have changes in access to the means of suicide resulted in changes to methods used and affected rates of suicide and 
suicidal behavior? For example, has suicide by firearms, pesticides, and medications increased as a result of people 
 stockpiling these? Have rail suicides decreased due to travel restrictions?
Media reporting How does the media report on COVID-19 and on COVID-19-related suicides, and what is the impact of this reporting on 
 suicide and suicidal behavior? For example, are suicide-related narratives different compared with pre-COVID-19?
Social media 
use and other 
online activity
Have patterns of social media usage/consumption and other online activity changed during the pandemic, and, if so, is this 
associated with suicidal behavior? For example, does repeated exposure to information about the pandemic heighten fear 
and increase the risk of suicide and suicidal behavior? Or does the connectedness afforded by digital technologies counter 
the isolation effects of physical distancing?
Ways we live and 
behave
Has the pandemic changed the way we live and behave, or will it do so in the future? If so, which changes are beneficial and 
which are harmful with respect to the risk of suicide and suicidal behavior?
High-risk groups
COVID-19 related high-risk groups
Bereaved Are people who have lost someone to COVID-19 at increased risk of suicide and suicidal behavior?
Vulnerability to 
COVID-19
Do people who may be particularly vulnerable to COVID-19 (e.g., older people, those living with chronic conditions or other 
medical complications) have elevated risk of suicide and suicidal behavior?
Infected by 
COVID-19
Are people who are recovering or have recovered from COVID-19 at increased risk of suicidal behavior? Are there 
 neurobiological mechanisms that mediate any increased risk for these people? Are people experiencing longer-term 
 physical consequences of COVID-19 infection at increased risk of suicide and suicidal behavior?
Frontline care 
workers
Is there an increased risk of suicide and suicidal behavior among frontline health and social care staff who are looking after 
patients with COVID-19? If so, is this risk associated with exposure to the virus, loss and grief, ethical challenges of having to 
make unprecedented choices, or something else?
Other high-risk groups
Mental health 
problems
Has the risk of suicide and suicidal behavior increased for people with pre-existing mental health problems?
Suicide 
 attempters
Are there increased numbers of people who make suicide attempts without presenting to hospital?
Economically 
affected and 
high-risk occu-
pational groups
Are people whose economic circumstances have been adversely affected by the pandemic (e.g., those who have lost 
their jobs, those whose businesses have folded) at increased risk of suicide and suicidal behavior? What is the impact of 
COVID-19 on suicide and suicidal behavior in different occupational groups, e.g., health-care staff, those working in the 
retail sector, artists, and groups in precarious working conditions?
Table continued next page
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iors (Mars et al., 2019; May & Klonsky, 2016). The collab-
oration provides a mechanism to work together, pool data 
using shared protocols, and investigate different outcomes 
with a range of research designs. It should also facilitate 
reaching global consensus on issues such as the impact 
of lockdown on suicide risk and how best to mitigate risk, 
especially if further periods are required to address the 
re-emergence of COVID-19, as has recently been report-
ed in countries such as Iran (Worldo meters, 2020).  
The collaboration has identified several suggestions for 
research to help inform responses to the current and future 
pandemics, formulating these as research questions (see 
General population
Young people Are children and adolescents at increased risk of suicidal behavior as a result of factors such as changes to their educational 
and vocational opportunities and reduced face-to-face contact with their peers? Are there particularly sensitive developmen-
tal stages or ages where interruptions will have the greatest impact on suicide and suicidal behavior in adulthood? What is the 
impact of COVID-19 on trends in suicide and suicidal behavior among children, adolescents, and young adults?
Older people Are older people at increased risk? What are the impacts of bereavement, loneliness, vulnerability to COVID-19, and stigma? 
Do living arrangements (e.g., living alone, living in aged care facilities) have an influence on risk?
Migrants/ 
refugees and 
displaced 
people
Is there an increased risk of suicide and suicidal behavior for migrants who may be living without a job in their host country 
or being forced to return to their native country? And what about refugees and displaced people living in camps with limited 
access to support or care? Are there differences between migrant groups and are refugees, asylum-seekers, and irregular 
migrants at increased risk of suicidal behavior?
Table 2. continued
Table 3. Example research questions relating to whether particular approaches/responses might help to mitigate any risk of suicide and/or suicidal 
behavior associated with the pandemic
Mental health 
consequences 
of lockdown
Are there country- or region-level differences in the pandemic response that are associated with greater or lesser changes 
in rates of suicide and suicidal behavior? For example, does the timing, scale, intensity, and duration of lockdown make 
a difference? What about the way physical distancing measures are enforced? Does the extent to which the public buys 
into and observes the restrictions (and whether this changes as time goes by) impact on any changes seen in suicide and 
suicidal behavior? Does it make a difference whether the lockdown is a well-articulated and coordinated national strategy 
or whether it is more fragmented in its conceptualization and implementation?
Do rates of suicide and suicidal behavior vary across different stages of the pandemic (e.g., during lockdown, once restric-
tions are eased), and what does this tell us about particular lockdown policies? Similarly, do sales of prescription psycho-
tropic medication and/or use of mental health services vary by pandemic stage, and what can we learn from this?
How can social networks be activated to identify and provide support to people who may be struggling due to lockdown?
How can care best be delivered to suicidal individuals when people are unable or afraid to leave their homes?
Economic 
 consequences 
of the pandemic
What can we learn from responses to previous pandemics or epidemics (e.g., the 2003 SARS outbreak) and economic crises 
(e.g., the 2008 recession) to inform our response to COVID-19?
Are there country- or region-level differences in economic responses that are associated with greater or lesser changes 
in rates of suicide and suicidal behavior? For example, do income guarantees, employment protection, and labor market 
programs make a difference? What about equity of access to resource provision?
Burden of 
mortality from 
COVID-19
How can care best be provided to individuals who have been bereaved through COVID-19 and to individuals who have been 
bereaved by suicide during the pandemic?
What sort of interventions might improve media reporting in relation to deaths due to COVID-19 and suicides during the 
pandemic?
Health-care 
and crisis line 
responses
How is availability of mental health services related to risk of suicide and suicidal behavior? Are there ways of scaling up 
mental health-care delivery?
How does knowledge of sociodemographic and clinical risk factors and neurobiological mechanisms inform prevention/
treatment approaches? 
What are the best ways to reach out to people who are not in touch with services? How can we encourage help-seeking?
How can mental health services best be delivered to suicidal individuals during the pandemic? How well do telehealth and 
online options work? Is it possible to identify and evaluate new forms of health-care services based on experiences and 
adaptations during the pandemic?
How can general health and mental health professionals be trained to respond effectively to suicidal clients or patients 
during the course of the pandemic? Do they need to learn new ways of operating?
Have crisis lines providing telephone and online chat support been used as resources for suicide prevention during the 
pandemic? Has the use of these sorts of services by suicidal individuals increased? Do people find them helpful?
Workplaces and 
educational 
institutions
How can workplaces help mitigate the risk of suicide and suicidal behavior during the pandemic? Are there ways they can 
support workers who may be working fewer hours or taking home less pay? And can they play a role in helping workers who 
may have lost their jobs?
How can schools and universities keep students positive, motivated, and safe during the pandemic?
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Table 2 and Table 3). The proposed research questions link 
to the gaps in knowledge that we identified earlier. Table 2 
highlights research questions relating to whether rates of 
suicidal behavior increase as a result of the pandemic and 
what mechanisms may be driving any increase, suggesting 
specific research for the general population and for high-
risk groups. Table 3 presents research questions relating 
to whether particular responses might help to mitigate any 
risk of suicide associated with the pandemic. Members 
of the collaboration have worked with the International 
Association for Suicide Prevention (IASP) to establish a 
searchable on-line list of ongoing COVID-relevant studies 
on suicidal behavior, managing suicidal crises, and suicide 
prevention (https://www.iasp.info/covid-19/covid-19-sui 
cide-research-studies) to facilitate collaboration and avoid 
duplication, similar to the website developed for longitu-
dinal studies on mental health during COVID-19 (https://
www.covidminds.org/longitudinalstudies). The role of the 
IASP, in collaboration with other international and nation-
al organizations (e.g., WHO, International Association of 
Suicide Research [IASR], American Foundation for Suicide 
Prevention [AFSP], and others), is to provide up-to-date in-
formation on suicide research and prevention in its global 
network. The IASP is developing a strategic plan to reduce 
COVID-19-related suicidal behavior and building a cen-
tral pool of resources (expertise, research, guidelines for 
good practice, briefings) that will be available to support 
organizations globally (IASP, 2020a, b). Members of the 
ICSPRC have contributed to an IASP briefing paper on re-
porting suicide during the COVID-19 pandemic and IASP 
members have developed guidance to help workplaces and 
professional associations through the COVID-19 Crisis 
(IASP, 2020a, b). The combination of the specific research 
focus in the ICSPRC and IASP, with its prevention network 
and links to the WHO, as the leading organization for sui-
cide prevention globally, is a core strength of this collabo-
ration and many members are active in both. 
A key issue the group needs to consider is how best to 
ensure the rapid dissemination of research and surveil-
lance information to inform policy-making and preven-
tion activities. Furthermore, there is a need to consider 
the best way of responding to (sometimes unsubstantiat-
ed) findings reported in news articles that may be hastily 
picked up by policy-makers and politicians. Three sorts of 
information are relevant: (a) routinely available data (e.g., 
national mortality, survey data, research publications) that 
not everyone will be aware of – this could be disseminated 
via regular briefings/updates; (b) pre-publication research 
data and findings that may inform policy, but are going 
through peer review – one possible approach to sharing 
these data is via regular webinars/research presentations; 
and (c) highly sensitive surveillance data, for example, 
known only to government officials and individuals on na-
tional suicide prevention strategy groups who have agreed 
not to disclose them. The latter data are unlikely to be 
shareable, but it will be important to consider approaches 
to share broad findings to give those working in different 
settings the opportunity to act pre-emptively and before 
local data are available. 
Facilities for sharing data/measures/protocols/pre-
peer-reviewed manuscripts (e.g., the Open Science Frame-
work and PsyArXiv) are possible options for building a re-
pository of research that can have a digital object identifier 
(DOI) and thus are traceable and citable. Crisis now also 
publishes Registered Reports, which allow authors to sub-
mit research protocols for review before the research is 
conducted. 
Conclusion 
The unique challenges posed by the current pandemic 
require suicide researchers to collaborate in order to un-
derstand the impact of COVID-19 on suicide and suicidal 
behavior and effective ways of mitigating the risk. We urge 
colleagues to complete the recently launched register of su-
icide prevention research studies to facilitate this (https://
www.iasp.info/covid-19/covid-19-suicide-re search-stud-
ies). In a challenging economic environment, suicide re-
searchers will need to advocate strongly for the importance 
of the issues we have identified and make sure the research 
that is conducted is of the highest possible quality and eth-
ical standard to inform public health, policy, and health-
care responses. Lessons learned and subsequent changes 
made will contribute to improving response plans for future 
possible waves in this pandemic and future pandemics. The 
establishment of the International  COVID-19 Suicide Pre-
vention Research Collaboration is an important contribu-
tion to this effort and we ask suicide researchers particular-
ly from regions currently not represented to join us.
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